Sign inGet started

Woods Keith

Insider CIK 1996804 · RCKT Director · NGNE Director · XFOR Director · SRRK Chief Operating Officer · TCRX Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
SRRK Scholar Rock Holding Corp G Gift2026-09-242026-09-2548,034— $0572,021SEC↗
SRRK Scholar Rock Holding Corp G Gift2026-09-242026-09-2548,034— $0572,021SEC↗
TCRX TScan Therapeutics, Inc. A Award deriv2026-05-202026-05-2267,000— $067,000SEC↗
SRRK Scholar Rock Holding Corp S Sale2026-04-162026-04-2010,220$49.57 $506.6K620,055SEC↗
NGNE Neurogene Inc. A Award deriv2026-02-202026-02-2412,050— $012,050SEC↗
SRRK Scholar Rock Holding Corp A Award2026-02-092026-02-1147,021— $0630,275SEC↗
SRRK Scholar Rock Holding Corp S Sale2026-01-132026-01-1516,746$42.70 $715.1K583,254SEC↗
TCRX TScan Therapeutics, Inc. A Award deriv2025-06-302025-07-0267,000— $067,000SEC↗
NGNE Neurogene Inc. A Award deriv2025-06-122026-06-1612,050— $012,050SEC↗
XFOR X4 Pharmaceuticals, Inc A Award2025-06-092025-06-101,500— $06,000SEC↗
SRRK Scholar Rock Holding Corp A Award deriv2025-05-022025-05-06110,067— $0110,067SEC↗
SRRK Scholar Rock Holding Corp A Award2025-04-272025-04-29500,000— $0600,000SEC↗
SRRK Scholar Rock Holding Corp A Award2025-04-272025-04-29100,000— $0100,000SEC↗
NGNE Neurogene Inc. A Award deriv2024-06-142026-06-167,700— $07,700SEC↗
RCKT ROCKET PHARMACEUTICALS, IN A Award deriv2024-06-132024-06-2023,944— $023,944SEC↗
TCRX TScan Therapeutics, Inc. A Award deriv2024-06-122024-06-1447,500— $047,500SEC↗
XFOR X4 Pharmaceuticals, Inc A Award2024-06-102024-06-1145,000— $0135,000SEC↗
NGNE Neurogene Inc. A Award deriv2024-01-162026-06-1615,400— $015,400SEC↗
RCKT ROCKET PHARMACEUTICALS, IN A Award deriv2023-12-072023-12-1220,522— $020,522SEC↗
RCKT ROCKET PHARMACEUTICALS, IN A Award deriv2023-12-072023-12-1211,960— $011,960SEC↗
TCRX TScan Therapeutics, Inc. A Award deriv2023-12-062023-12-0817,500— $017,500SEC↗
XFOR X4 Pharmaceuticals, Inc A Award2023-10-162023-10-1890,000— $090,000SEC↗